PP_1170x120_10-25-21

critical subset of antibodies known to protect against SARS-CoV-2 viral infections

Vyriad develops antibody test for COVID-19

Vyriad develops antibody test for COVID-19

ROCHESTER, Minn. — Vyriad announced Tuesday that it has completed the development of a serology test to measure protective immunity against SARS-CoV-2, the novel coronavirus that causes COVID-19. The Vyriad SARS-CoV-2 Neutralizing Antibody Test detects neutralizing antibodies, the critical subset of antibodies known to protect against SARS-CoV-2 viral infections. The ability to reliably identify these